StockData

Dyadic International vs Pluri

DYAI and PLUR side by side, both in drugs. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.

How DYAI and PLUR compare

Dyadic International and Pluri are about the same size, with market caps of $11.5M and $12.1M.

Dyadic International grew revenue faster over the last twelve months (−7.6% versus −24.0% for Pluri).

Dyadic International keeps more of each dollar of sales as profit, with a net margin of −227% compared with −2345% at Pluri.

Dyadic International scores higher on the StockData Score (7 against 2 for Pluri), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.

Key numbers

A dot marks the better figure where higher or lower is clearly better.

MetricDYAIPLUR
Size and price
Market cap$11.5M$12.1M
Share price$0.316$0.980
Change, 1 year−65.4%−74.6%
Change, 5 years−91.5%−95.4%
Beta (5Y)1.460.05
Employees592
StockData Score
Total score7 (better)2
Valuation score1 (better)0
Growth score01 (better)
Performance score11
Health score5 (better)0
Dividend score00
Valuation
P/S3.7× (better)11.9×
FCF yield–−167%
Growth
Revenue growth (TTM)−7.6% (better)−24.0%
Revenue growth, 5Y average14.0%–
Profitability
Gross margin17.9%44.6% (better)
Operating margin−237% (better)−2455%
Net margin−227% (better)−2345%
FCF margin–−1990%
Return on equity−47256%–
Financial health
Interest coverage–−26.8×
Current ratio1.69 (better)0.27
Altman Z-score−18.96 (better)−30.53
Piotroski F-score2 (better)1
Dividends and buybacks
Buyback yield–−41.9%
Shareholder yield0.00% (better)−41.9%
Ownership
Held by institutions12.7%0.22%
Held by insiders28.0%54.6%
Insider net buying, 12 months−$125K$1.3M (better)
Short interest, % of float0.32%1.4%

Go deeper

For information only, not investment advice. Check the source filings before relying on any figure.